Increased expression of the p27(KIP1) protein in human esophageal cancer cell lines that over-express cyclin D1

Carcinogenesis

Volumn 18, Issue 6, 1997, Pages 1139-1148

  Doki, Yuichiro ^a   Imoto, Masaya ^a   Han, Edward Kyu Ho ^a   Sgambato, Alessandro ^a   Weinstein, I Bernard ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; COMPLEMENTARY DNA; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P27; RETINOBLASTOMA PROTEIN; CARRIER PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGUS CANCER; FEEDBACK SYSTEM; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG ANTAGONISM; ESOPHAGUS TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; ESOPHAGEAL NEOPLASMS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0031284667     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.6.1139     Document Type: Article

References (63)

1. Hunter, T. and Pines, J. (1994) Cyclins and cancer II: cyclin D and Cdk inhibitors come of age. Cell, 79, 573-582.
2. Sherr, C.J. (1994) G1 phase progression: cycling on cue. Cell, 79, 551-555.
3. Nurse, P. (1994) Ordering S phase and M phase in the cell cycle. Cell, 79, 547-550.
4. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
5. Kato, J., Matsushime, H., Hiebert, S.W., Ewan, M.E. and Sherr, C.J. (1993) Direct binding of cyclin D to the retinoblastoma product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7, 331-342.
6. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J. and Kato, J.-Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14, 2066-2076.
7. Beijersbergen, R.L., Carlee, L., Kerkhoven, R.M. and Bernards, R. (1995) Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev., 9, 1340-1353.
8. Li, Y., Graham, C., Lacy, S., Duncan, A.M.V. and Whyte, P. (1993) The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev., 1, 2366-2377.
9. Harper, J.W., Adami, G., Wei, N., Keyomarsi, K. and Elledge, S.J. (1993) The p21kd Cdk interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
10. Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1-cyclin-cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
11. Lee, M.H., Renisdottir, I. and Massague, J. (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9, 639-649.
12. INK4B is a potential effector of TGFβ induced cell cycle arrest. Nature, 371, 257-261.
13. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
14. 14INK4B/MTS2- related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8, 2939-2952.
15. Jiang, W., Kahn, S.M., Zhou, P., Zhang, Y.-J., Cacace, A.M., Infante, A.S., Doi, S., Santella, R.M., and Weinstein, I.B. Over-expression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8, 3447-3457.
16. Quelle, D.E., Ashmun, R.A., Shurtleff, S.A., Kato J.Y., Bar-Sagi, D., Roussel, M.F. and Sherr, C. J. (1993) Over-expression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev., 7, 1559-1571.
17. Ohtsubo, M. and Roberts, J.M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science, 259, 1908-1912.
18. Resnitzky, D., Gossen, M., Bujard, H. and Reed, S. I. (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14, 1669-1679.
19. Han, E.K., Sgambato, A., Jiang, W., Zhang, Y.J., Santella, R.M., Doki, Y., Cacace, A.M., Schieren, I. and Weinstein, I.B. (1995) Stable over-expression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene, 10, 953-961.
20. Atadja, P., Wong, H., Veillete, C. and Riabowol, K. (1995) Over-expression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp. Cell Res., 217, 205-216.
21. KIP1, inhibits growth and enhances apoptosis. Cell Growth Diff., 7, 699-710.
22. KIP1 inhibitor protein. Cancer Res., 56, 1389-1399.
23. Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A.A., Jansen-Dür, P., Strauss, M. and Bartek, J. (1994) DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol., 125, 625-638.
24. Müller, H., Lukas, J., Schneider, A., Warthoe, P., Bartek, J., Eilers, M. and Strauss, M. (1994) Cyclin D1 expression is regulated by the retinoblstoma protein. Proc. Nat. Acad. Sci., 91, 2945-2949.
25. INK4/MTS1 tumor suppressor gene product. EMBO J., 14, 503-511.
26. Aagaard, L., Lukas, J., Bartkova, J., Kjerulef, A.-A., Strauss, M. and Bartek, J. (1995) Aberrations of p16INK4 and retinoblastoma tumor-suppressor gene occur in distinct sub-sets of human cancer cell lines. Int. J. Cancer, 61, 115-120.
27. Ewen, M.E., Sluss, H.K., Whitehouse, L.L. and Livingston, D.M. (1993) TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell, 74, 1009-1020.
28. Geng, Y. and Weinberg, R.A. (1993) Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl Acad. Sci USA, 90, 10315-10319.
29. KIP1, a cyclin-cdk inhibitor, links transforming growth factor-β = beta and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
30. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J. and Reed, S.I. (1994) P53-dependent inhibition of cyclin dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023.
31. Li, R., Waga, S., Hannon, G.J., Beach, D. and Stillman, B. (1994) Differential effects by p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature, 371, 534-537.
32. Lucibello, F., Sewing, A., Brusselbach, S., Burger, C. and Muller, R. (1993) Deregulation of cyclin D1 and E and suppression of Cdk2 and Cdk 4 in senescent human fibroblasts. J. Cell Sci., 105, 123-133.
33. Horiguchi-Yamada, J., Yamada, H., Nakada, S., Ochi, K. and Nemoto, T. (1994) Changes of G1 cyclins, cdk2, and cyclin A during the differentiation of HL60 cells induced by TPA. Mol. Cell Biochem., 132, 31-37.
34. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H.J. and Pardee, A.B. (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54, 380-385.
35. Jiang, W., Zhang, Y.-J., Kahn, S.M., Hollestein, M.C., Santella, R.M., Lu, S.H., Harris, C.C., Montesano, R. and Weinstein, I.B. (1993) Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl Acad. Sci. USA, 90, 9026-9030.
36. Adelaide, J., Monges, G., Derderian, C., Seitz, J.F. and Birnbaum, D. (1995) Oesophageal cancer and amplification of the human cyclin D gene CCND1/ PRAD1. Br. J. Cancer, 71, 64-68.
37. Nakagawa, H., Zunkerberg, L., Togawa, K., Meltzer, S.J., Nishihara, T. and Rustagi, A.K. (1995) Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer, 76, 541-549.
38. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J. and Kato, J.-Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14, 2066-2076.
39. Zar, J.H. (1974) Biostatistical Analysis. Prentice-Hall, Inc., Englewood Cliffs, NJ.
40. Guadagno, T.M. and Newport, J.W. (1996) Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell, 84, 73-82.
41. Slingerland, J.M., Hengst, L., Pan, C.H., Alexander, D., Stampfer, M.R. and Reed, S.I. (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol., 14, 3683-3694.
42. Iihara, K., Shiozaki, H., Oku, K., Tahara, H., Doki, Y., Oka, H., Kadowaki, T. Iwazawa, T., Inoue, M. and Mori, T. (1993) Growth-regulatory mechanism of two human esophageal-cancer cell lines in protein-free conditions. Int. J. Cancer, 55, 364-370.
43. Bartkova, J., Lukas, J., Strauss, M. and Bartek, J. (1995) Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10, 775-778.
44. Zhang, S.Y., Caamano, J., Cooper, F., Guo, X. and Klein-Szanto, A.J. (1994) Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Path., 102, 695-698.
45. Bartkova, J., Lukas, J., Strauss, M. and Bartek, J. (1994) The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int. J. Cancer, 58, 568-573.
46. Arber, N., Hibshoosh, S.F., Moss, T., Sutter, Y., Zhang, M., Begg, S., Wang, S., Weinstein, I.B. and Holt, P.R. (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110, 669-674.
47. Leach, F.S., Elledge, S.J., Sherr, C.J., Willson, J.K., Markowitz, S., Kinzler, K.W. and Vogelstein, B. (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53, 1986-1989.
48. Yoshida, T., Sakamoto, H. and Terada, M. (1993) Amplified genes in cancer in upper digestive tract. Sem. Cancer Biol., 4, 33-40.
49. Liu, J.J., Chao, J.R., Jiang, M.C., Ng, S.Y., Yen, J.J. and Yang-Yen, H.F. (1995) Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol., 15, 3654-3663.
50. Filmus, J., Robles, A.I., Shi, W., Wong, M.J., Colombo, C.L. and Conti, C.J. (1994) Induction of cyclin D1 over-expression by activated ras. Oncogene, 9, 3627-3633.
51. Arber, N., Sutter, T., Miyake, M., Kahn, S., Venkatraj, V.S., Sobrino, A., Warburton, D., Holt, P.R. and Weinstein, I.B. (1996) Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene, 12, 1903-1908.
52. Wei, J., Kahn, S.M., Guillem, J.G., Lu, S.-H. and Weinstein, I.B. (1989) Rapid detection of ras oncogene in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene, 4, 923-928.
53. Galiana, C., Fusco, A., Martel, N., Nishihira, T., Hirohashi, S. and Yamasaki, H. (1993) Possible role of activated ras genes in human esophageal carcinogenesis. Int. J. Cancer, 54, 978-982.
54. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M. and Bartek, J. (1994) Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57, 353-361.
55. Schauer, I.E., Siriwardana, S., Langan, T.A. and Sclafani, R.A. (1994) Cyclin D1 over-expression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc. Natl Acad. Sci., USA, 91, 7827-7831.
56. MST1 gene status in human esophageal carcinoma cell lines. J. Expt. Therapeut. Oncol., 1, 7-12.
57. KIP1 accumulation during the cell cycle. Science, 271, 1861-1863.
58. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Sal, G.D., Chau, V., Yew, P.R., Draetta, G.F. and Rolfe, M. (1995) Role of the ubiquitin-proteasome pathway in regulation abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685.
59. Igaki, H., Sasaki, H., Tachimori, Y., Kato, H., Watanabe, H., Kimura, T., Harada, Y., Sugimura, T. and Terada, M. (1995) Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res., 55, 3421-3423.
60. Qingyun, L., Yan, Y.-X., McClure, M., Nakagawa, H., Fujimura, F. and Rustgi, A.K. (1995) MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Oncogene, 10, 619-622.
61. Zhou, X., Suzuki, H., Shimada, Y., Imamura, M., Yin, J., Jiang, H.-Y., Tarmin, L., Abraham, J.M. and Meltzer, S.J. (1995) Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines. Genes, Chromosomes Cancer, 13, 285-290.
62. Enders, G.H., Koh, J., Missero, C., Rustgi, A.K. and Harlow, E. (1996) p16 inhibition of transformed and primary squamous epithelial cells. Oncogene, 12, 1239-1245.
63. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S. and Nakamura, Y. (1994) Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/ cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397.